{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:52:44Z","timestamp":1793137964969,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009633","name":"U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["1R01HD102545-01A1"],"award-info":[{"award-number":["1R01HD102545-01A1"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Genet"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s10038-025-01353-x","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T23:24:46Z","timestamp":1749511486000},"page":"463-473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessment of different promoters in lentiviral vectors for expression of the N-acetyl-galactosamine-6-sulfate sulfatase gene"],"prefix":"10.1038","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0379-8076","authenticated-orcid":false,"given":"Betul","family":"Celik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5956-1986","authenticated-orcid":false,"given":"Andr\u00e9s Felipe","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7689-1258","authenticated-orcid":false,"given":"Shaukat","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0673-2160","authenticated-orcid":false,"given":"Shunji","family":"Tomatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"1353_CR1","doi-asserted-by":"crossref","unstructured":"Celik B, Tomatsu SC, Tomatsu S, Khan SA. Epidemiology of mucopolysaccharidoses update. Diagnostics. 2021;11:273.","DOI":"10.3390\/diagnostics11020273"},{"key":"1353_CR2","unstructured":"HGMD\u00ae gene result. GALNS. 2023. Available from: http:\/\/www.hgmd.cf.ac.uk\/ac\/gene.php?gene=GALNS."},{"key":"1353_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ymgme.2018.05.004","volume":"125","author":"H Peracha","year":"2018","unstructured":"Peracha H, Sawamoto K, Averill L, Kecskemethy H, Theroux M, Thacker M, et al. Molecular genetics and metabolism, special edition: diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA. Mol Genet Metab. 2018;125:18\u201337.","journal-title":"Mol Genet Metab"},{"key":"1353_CR4","doi-asserted-by":"crossref","unstructured":"Sawamoto K, Gonz\u00e1lez JV\u00c1, Piechnik M, Otero FJ, Couce ML, Suzuki Y, et al. Mucopolysaccharidosis IVA: diagnosis, treatment, and management. Int J Mol Sci. 2020;21. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32102177\/.","DOI":"10.3390\/ijms21041517"},{"key":"1353_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ymgme.2016.04.005","volume":"118","author":"E Yasuda","year":"2016","unstructured":"Yasuda E, Suzuki Y, Shimada T, Sawamoto K, Mackenzie WG, Theroux MC, et al. Activity of daily living for Morquio A syndrome. Mol Genet Metab. 2016;118:111\u201322.","journal-title":"Mol Genet Metab"},{"key":"1353_CR6","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3390\/ijms21030989","volume":"21","author":"A Nakamura-Utsunomiya","year":"2020","unstructured":"Nakamura-Utsunomiya A, Nakamae T, Kagawa R, Karakawa S, Sakata S, Sakura F, et al. A case report of a Japanese boy with Morquio A syndrome: effects of enzyme replacement therapy initiated at the age of 24 months. Int J Mol Sci. 2020;21:989.","journal-title":"Int J Mol Sci"},{"key":"1353_CR7","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s10038-019-0604-6","volume":"64","author":"C Doherty","year":"2019","unstructured":"Doherty C, Stapleton M, Piechnik M, Mason RW, Mackenzie WG, Yamaguchi S, et al. Effect of enzyme replacement therapy on the growth of patients with Morquio A. J Hum Genet. 2019;64:625\u201335.","journal-title":"J Hum Genet"},{"key":"1353_CR8","first-page":"42","volume":"9","author":"J Do Cao","year":"2016","unstructured":"Do Cao J, Wiedemann A, Quinaux T, Battaglia-Hsu SF, Mainard L, Froissart R, et al. 30 months follow-up of an early enzyme replacement therapy in a severe Morquio A patient: about one case. Mol Genet Metab Rep. 2016;9:42\u20135.","journal-title":"Mol Genet Metab Rep"},{"key":"1353_CR9","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1002\/ajmg.a.62469","volume":"185","author":"M Frigeni","year":"2021","unstructured":"Frigeni M, Rodriguez-Buritica DF, Saavedra H, Gunther KA, Hillman PR, Balaguru D, et al. The youngest pair of siblings with mucopolysaccharidosis type IVA to receive enzyme replacement therapy to date: a case report. Am J Med Genet A. 2021;185:3510\u20136.","journal-title":"Am J Med Genet A"},{"key":"1353_CR10","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/diagnostics10020108","volume":"10","author":"S Barak","year":"2020","unstructured":"Barak S, Anikster Y, Sarouk I, Stern E, Eisenstein E, Yissar T, et al. Long-term outcomes of early enzyme replacement therapy for mucopolysaccharidosis IV: clinical case studies of two siblings. Diagnostics. 2020;10:108.","journal-title":"Diagnostics"},{"key":"1353_CR11","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s40262-014-0173-y","volume":"53","author":"Y Qi","year":"2014","unstructured":"Qi Y, Musson DG, Schweighardt B, Tompkins T, Jesaitis L, Shaywitz AJ, et al. Pharmacokinetic and pharmacodynamic evaluation of elosulfase alfa, an enzyme replacement therapy in patients with Morquio A syndrome. Clin Pharmacokinet. 2014;53:1137\u201347.","journal-title":"Clin Pharmacokinet"},{"key":"1353_CR12","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1517\/21678707.2015.1086640","volume":"3","author":"S Tomatsu","year":"2015","unstructured":"Tomatsu S, Sawamoto K, Shimada T, Bober MB, Kubaski F, Yasuda E, et al. Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations. Expert Opin Orphan Drugs. 2015;3:1279\u201390.","journal-title":"Expert Opin Orphan Drugs"},{"key":"1353_CR13","first-page":"2686","volume":"118","author":"KP Ponder","year":"2008","unstructured":"Ponder KP, Immune response hinders therapy for lysosomal storage diseases. J Clin Invest. 2008;118:2686\u20139.","journal-title":"J Clin Invest"},{"key":"1353_CR14","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.clinthera.2016.11.017","volume":"39","author":"B Long","year":"2017","unstructured":"Long B, Tompkins T, Decker C, Jesaitis L, Khan S, Slasor P, et al. Long-term immunogenicity of elosulfase alfa in the treatment of morquio a syndrome: results from MOR-005, a phase III extension study. Clin Ther. 2017;39:118\u2013129.e3.","journal-title":"Clin Ther"},{"key":"1353_CR15","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.clinthera.2014.11.005","volume":"37","author":"B Schweighardt","year":"2015","unstructured":"Schweighardt B, Tompkins T, Lau K, Jesaitis L, Qi Y, Musson DG, et al. Immunogenicity of elosulfase alfa, an enzyme replacement therapy in patients with Morquio A syndrome: results from MOR-004, a phase III trial. Clin Ther. 2015;37:1012\u20131021.e6.","journal-title":"Clin Ther"},{"key":"1353_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jim.2016.10.006","volume":"440","author":"AC Melton","year":"2017","unstructured":"Melton AC, Soon RK, Tompkins T, Long B, Schweighardt B, Qi Y, et al. Antibodies that neutralize cellular uptake of elosulfase alfa are not associated with reduced efficacy or pharmacodynamic effect in individuals with Morquio A syndrome. J Immunol Methods. 2017;440:41\u201351.","journal-title":"J Immunol Methods"},{"key":"1353_CR17","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/hmg\/ddm353","volume":"17","author":"S Tomatsu","year":"2008","unstructured":"Tomatsu S, Monta\u00f1o AM, Ohashi A, Gutierrez MA, Oikawa H, Oguma T, et al. Enzyme replacement therapy in a murine model of Morquio A syndrome. Hum Mol Genet. 2008;17:815\u201324.","journal-title":"Hum Mol Genet"},{"key":"1353_CR18","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ymgme.2013.12.057","volume":"1","author":"Y Chinen","year":"2014","unstructured":"Chinen Y, Higa T, Tomatsu S, Suzuki Y, Orii T, Hyakuna N. Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA. Mol Genet Metab Rep. 2014;1:31\u201341.","journal-title":"Mol Genet Metab Rep"},{"key":"1353_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ymgme.2015.09.011","volume":"117","author":"H Yabe","year":"2016","unstructured":"Yabe H, Tanaka A, Chinen Y, Kato S, Sawamoto K, Yasuda E, et al. Hematopoietic stem cell transplantation for Morquio A syndrome. Mol Genet Metab. 2016;117:84\u201394.","journal-title":"Mol Genet Metab"},{"key":"1353_CR20","doi-asserted-by":"crossref","unstructured":"Piechnik M, Amendum PC, Sawamoto K, Stapleton M, Khan S, Fnu N, et al. Sex difference leads to differential gene expression patterns and therapeutic efficacy in mucopolysaccharidosis IVA murine model receiving AAV8 gene therapy. Int J Mol Sci. 2022;23:12693.","DOI":"10.3390\/ijms232012693"},{"key":"1353_CR21","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1016\/j.bbmt.2016.08.015","volume":"22","author":"J Wang","year":"2016","unstructured":"Wang J, Luan Z, Jiang H, Fang J, Qin M, Lee V, et al. Allogeneic hematopoietic stem cell transplantation in thirty-four pediatric cases of mucopolysaccharidosis-a ten-year report from the China children transplant group. Biol Blood Marrow Transpl. 2016;22:2104\u20138.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1353_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1074-9","volume":"14","author":"MU Akyol","year":"2019","unstructured":"Akyol MU, Alden TD, Amartino H, Ashworth J, Belani K, Berger KI, et al. Recommendations for the management of MPS IVA: systematic evidence- and consensus-based guidance. Orphanet J Rare Dis. 2019;14:137.","journal-title":"Orphanet J Rare Dis"},{"key":"1353_CR23","doi-asserted-by":"publisher","first-page":"e226","DOI":"10.1016\/j.bbmt.2019.02.012","volume":"25","author":"M Taylor","year":"2019","unstructured":"Taylor M, Khan S, Stapleton M, Wang J, Chen J, Wynn R, et al. Hematopoietic stem cell transplantation for mucopolysaccharidoses: past, present, and future. Biol Blood Marrow Transplant. 2019;25:e226\u201346.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1353_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ymgme.2017.12.434","volume":"123","author":"K Sawamoto","year":"2018","unstructured":"Sawamoto K, Chen HH, Alm\u00e9ciga-D\u00edaz CJ, Mason RW, Tomatsu S. Gene therapy for Mucopolysaccharidoses. Mol Genet Metab. 2018;123:59.","journal-title":"Mol Genet Metab"},{"key":"1353_CR25","doi-asserted-by":"publisher","first-page":"4139","DOI":"10.3390\/ijms20174139","volume":"20","author":"K Sawamoto","year":"2019","unstructured":"Sawamoto K, Tomatsu S. Development of substrate degradation enzyme therapy for mucopolysaccharidosis IVA murine model. Int J Mol Sci. 2019;20:4139.","journal-title":"Int J Mol Sci"},{"key":"1353_CR26","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1089\/hum.2024.094","volume":"35","author":"B Celik","year":"2024","unstructured":"Celik B, Rintz E, Sansanwal N, Khan S, Bigger B, Tomatsu S. Lentiviral vector-mediated ex vivo hematopoietic stem cell gene therapy for mucopolysaccharidosis IVA murine model. Hum Gene Ther. 2024;35:917\u201337.","journal-title":"Hum Gene Ther"},{"key":"1353_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4137\/BMI.S7451","volume":"6","author":"JP Hintze","year":"2011","unstructured":"Hintze JP, Tomatsu S, Fujii T, Monta\u00f1o AM, Yamaguchi S, Suzuki Y, et al. Comparison of liquid chromatography-tandem mass spectrometry and sandwich ELISA for determination of keratan sulfate in plasma and urine. Biomark Insights. 2011;6:69\u201378.","journal-title":"Biomark Insights"},{"key":"1353_CR28","doi-asserted-by":"crossref","unstructured":"Tomatsu S, Monta\u00f1o AM, Oguma T, Dung VC, Oikawa H, De Carvalho TG, et al. Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry. J Inherit Metab Dis. 2010;33:S35\u201342.","DOI":"10.1007\/s10545-009-9013-x"},{"key":"1353_CR29","doi-asserted-by":"crossref","unstructured":"Tomatsu S, Monta\u00f1o AM, Oguma T, Dung VC, Oikawa H, De Carvalho TG, et al. Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry. J Inherit Metab Dis. 2010 [cited 2023 Feb 1];33SUPPL. 3). Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/20107903\/.","DOI":"10.1007\/s10545-009-9013-x"},{"key":"1353_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ymgme.2018.04.011","volume":"125","author":"SA Khan","year":"2018","unstructured":"Khan SA, Mason RW, Giugliani R, Orii K, Fukao T, Suzuki Y, et al. Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis. Mol Genet Metab. 2018;125:44\u201352.","journal-title":"Mol Genet Metab"},{"key":"1353_CR31","doi-asserted-by":"crossref","unstructured":"Khan SA, Nidhi FNU, Amendum PC, Tomatsu S. Detection of Glycosaminoglycans in Biological Specimens. Methods Mol Biol. 2023;2619:3\u201324.","DOI":"10.1007\/978-1-0716-2946-8_1"},{"key":"1353_CR32","doi-asserted-by":"crossref","unstructured":"Leal AF, Alm\u00e9ciga-D\u00edaz CJ. Efficient CRISPR\/Cas9 nickase-mediated genome editing in an in vitro model of mucopolysaccharidosis IVA. Gene Ther. 2023;30:107\u2013114.","DOI":"10.1038\/s41434-022-00344-3"},{"key":"1353_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ymgme.2007.01.004","volume":"91","author":"S Tomatsu","year":"2007","unstructured":"Tomatsu S, Monta\u00f1o AM, Gutierrez M, Grubb JH, Oikawa H, Dung VC, et al. Characterization and pharmacokinetic study of recombinant human N-acetylgalactosamine-6-sulfate sulfatase. Mol Genet Metab. 2007;91:69\u201378.","journal-title":"Mol Genet Metab"},{"key":"1353_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.omtm.2020.05.015","volume":"18","author":"K Sawamoto","year":"2020","unstructured":"Sawamoto K, Karumuthil-Melethil S, Khan S, Stapleton M, Bruder JT, Danos O, et al. Liver-targeted AAV8 gene therapy ameliorates skeletal and cardiovascular pathology in a mucopolysaccharidosis IVA murine model. Mol Ther Methods Clin Dev [Internet]. 2020;18:50\u201361.","journal-title":"Mol Ther Methods Clin Dev [Internet]"},{"key":"1353_CR35","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1097\/JOM.0000000000000879","volume":"58","author":"R Schlimgen","year":"2016","unstructured":"Schlimgen R, Howard J, Wooley D, Thompson M, Baden LR, Yang OO, et al. Risks associated with lentiviral vector exposures and prevention strategies. J Occup Environ Med. 2016;58:1159\u201366.","journal-title":"J Occup Environ Med"},{"key":"1353_CR36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41591-021-01554-9","volume":"28","author":"F Boulad","year":"2022","unstructured":"Boulad F, Maggio A, Wang X, Moi P, Acuto S, Kogel F, et al. Lentiviral globin gene therapy with reduced-intensity conditioning in adults with \u03b2-thalassemia: a phase 1 trial. Nat Med. 2022;28:63\u201370.","journal-title":"Nat Med"},{"key":"1353_CR37","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1007\/s11033-008-9392-3","volume":"36","author":"CJ Alm\u00e9ciga-D\u00edaz","year":"2009","unstructured":"Alm\u00e9ciga-D\u00edaz CJ, Rueda-Paramo MA, Espejo AJ, Echeverri OY, Monta\u00f1o A, Tomatsu S, et al. Effect of elongation factor 1\u03b1 promoter and SUMF1 over in vitro expression of N-acetylgalactosamine-6-sulfate sulfatase. Mol Biol Rep. 2009;36:1863\u201370.","journal-title":"Mol Biol Rep"},{"key":"1353_CR38","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.ymthe.2004.02.017","volume":"9","author":"SP Zielske","year":"2004","unstructured":"Zielske SP, Lingas KT, Li Y, Gerson SL. Limited lentiviral transgene expression with increasing copy number in an MGMT selection model: lack of copy number selection by drug treatment. Molecular Ther. 2004;9:923\u201331.","journal-title":"Molecular Ther"},{"key":"1353_CR39","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/s41434-022-00315-8","volume":"29","author":"G Corre","year":"2022","unstructured":"Corre G, Seye A, Frin S, Ferrand M, Winkler K, Luc C, et al. Lentiviral standards to determine the sensitivity of assays that quantify lentiviral vector copy numbers and genomic insertion sites in cells. Gene Ther. 2022;29:536\u201343.","journal-title":"Gene Ther"},{"key":"1353_CR40","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1182\/blood-2006-12-060814","volume":"110","author":"F Zhang","year":"2007","unstructured":"Zhang F, Thornhill SI, Howe SJ, Ulaganathan M, Schambach A, Sinclair J, et al. Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells. Blood. 2007;110:1448\u201357.","journal-title":"Blood"},{"key":"1353_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2021.145527","volume":"780","author":"MA Puentes-Tellez","year":"2021","unstructured":"Puentes-Tellez MA, S\u00e1nchez OF, Rojas-Rodriguez F, Benincore-Fl\u00f3re E, Barbosa H, Alm\u00e9ciga D\u00edaz CJ. Evaluation of HIV\u20131 derived lentiviral vectors as transductors of Mucopolysaccharidosis type IV a fibroblasts. Gene. 2021;780:145527.","journal-title":"Gene"},{"key":"1353_CR42","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s00232-015-9799-4","volume":"248","author":"S Kos","year":"2015","unstructured":"Kos S, Tesic N, Kamensek U, Blagus T, Cemazar M, Kranjc S, et al. Improved specificity of gene electrotransfer to skin using pDNA under the control of collagen tissue-specific promoter. J Membr Biol. 2015;248:919\u201328.","journal-title":"J Membr Biol"},{"key":"1353_CR43","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s13402-018-0384-6","volume":"41","author":"O Karaosmano\u011flu","year":"2018","unstructured":"Karaosmano\u011flu O, Banerjee S, Sivas H. Identification of biomarkers associated with partial epithelial to mesenchymal transition in the secretome of slug over-expressing hepatocellular carcinoma cells. Cellular Oncol. 2018;41:439\u201353.","journal-title":"Cellular Oncol"},{"key":"1353_CR44","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1089\/hum.2017.097","volume":"29","author":"S Bougioukli","year":"2018","unstructured":"Bougioukli S, Sugiyama O, Pannell W, Ortega B, Tan MH, Tang AH, et al. Gene therapy for bone repair using human cells: superior osteogenic potential of Bone Morphogenetic Protein 2 \u2013transduced mesenchymal stem cells derived from adipose tissue compared to bone marrow. Hum Gene Ther. 2018;29:507\u201319.","journal-title":"Hum Gene Ther"},{"key":"1353_CR45","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1016\/j.ymthe.2020.07.006","volume":"28","author":"JF Wright","year":"2020","unstructured":"Wright JF. Quantification of CpG motifs in rAAV genomes: avoiding the toll. Molecular Ther. 2020;28:1756\u20138.","journal-title":"Molecular Ther"},{"key":"1353_CR46","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1136\/jmg.2003.018010","volume":"41","author":"S Tomatsu","year":"2004","unstructured":"Tomatsu S. Mucopolysaccharidosis IVA: identification of mutations and methylation study in GALNS gene. J Med Genet. 2004;41:e98\u2013e98.","journal-title":"J Med Genet"}],"container-title":["Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s10038-025-01353-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-025-01353-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s10038-025-01353-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T18:55:46Z","timestamp":1757184946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s10038-025-01353-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1353"],"URL":"https:\/\/doi.org\/10.1038\/s10038-025-01353-x","relation":{},"ISSN":["1434-5161","1435-232X"],"issn-type":[{"value":"1434-5161","type":"print"},{"value":"1435-232X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}